SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-17-000055
Filing Date
2017-08-08
Accepted
2017-08-08 17:03:47
Documents
98
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q valeantq22017.htm 10-Q 2487763
2 EXHIBIT 31.1 exhibit311q22017.htm EX-31.1 14543
3 EXHIBIT 31.2 exhibit312q22017.htm EX-31.2 14578
4 EXHIBIT 32.1 exhibit321q22017.htm EX-32.1 8850
5 EXHIBIT 32.2 exhibit322q22017.htm EX-32.2 8839
  Complete submission text file 0000885590-17-000055.txt   11828616

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vrx-20170630.xml EX-101.INS 2656735
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrx-20170630.xsd EX-101.SCH 81089
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrx-20170630_cal.xml EX-101.CAL 147350
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrx-20170630_lab.xml EX-101.LAB 958519
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrx-20170630_pre.xml EX-101.PRE 621168
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrx-20170630_def.xml EX-101.DEF 448320
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 171015575
SIC: 2834 Pharmaceutical Preparations